2025 annual financial data
TransCode Therapeutics 2025 Operating margin
TransCode Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -27,980,071 USD and net income was -34,661,076 USD.
Operating cash flow was -19,516,229 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,980,071 USD
- Net income
- -34,661,076 USD
- Operating cash flow
- -19,516,229 USD